Fig. 6From: Safety and antitumor activity of GD2-Specific 4SCAR-T cells in patients with glioblastomaCytokine modulation in peripheral blood after GD2 specific 4SCAR-T cell infusion. (A-G) Circulating levels of IL-6 and TNF-α in serum from indicated patientsBack to article page